Tower Research Capital (TRC)’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,717
| Closed | -$4.24K | – | 5485 |
|
|
2025
Q1 | $4.24K | Buy |
+7,717
| New | +$4.24K | ﹤0.01% | 4284 |
|
|
2024
Q4 | – | Sell |
-2,017
| Closed | -$1.78K | – | 5914 |
|
|
2024
Q3 | $1.78K | Sell |
2,017
-1,222
| -38% | -$1.08K | ﹤0.01% | 5104 |
|
|
2024
Q2 | $3.19K | Buy |
+3,239
| New | +$3.19K | ﹤0.01% | 4923 |
|
|
2024
Q1 | – | Sell |
-17
| Closed | -$23 | – | 6063 |
|
|
2023
Q4 | $23 | Buy |
+17
| New | +$23 | ﹤0.01% | 5813 |
|
|
2023
Q3 | – | Sell |
-2,639
| Closed | -$6.86K | – | 6137 |
|
|
2023
Q2 | $6.86K | Sell |
2,639
-13,378
| -84% | -$34.8K | ﹤0.01% | 4627 |
|
|
2023
Q1 | $19K | Buy |
16,017
+10,402
| +185% | +$12.3K | ﹤0.01% | 3499 |
|
|
2022
Q4 | $9K | Buy |
5,615
+1,802
| +47% | +$2.89K | ﹤0.01% | 4233 |
|
|
2022
Q3 | $5K | Sell |
3,813
-2,409
| -39% | -$3.16K | ﹤0.01% | 5158 |
|
|
2022
Q2 | $6K | Buy |
6,222
+5,275
| +557% | +$5.09K | ﹤0.01% | 4939 |
|
|
2022
Q1 | $2K | Sell |
947
-767
| -45% | -$1.62K | ﹤0.01% | 5580 |
|
|
2021
Q4 | $3K | Buy |
+1,714
| New | +$3K | ﹤0.01% | 5473 |
|
|
2021
Q3 | – | Sell |
-2,160
| Closed | -$6K | – | 6044 |
|
|
2021
Q2 | $6K | Buy |
+2,160
| New | +$6K | ﹤0.01% | 4635 |
|
|
2020
Q4 | – | Sell |
-60
| Closed | – | – | 5336 |
|
|
2020
Q3 | $0 | Buy |
+60
| New | – | ﹤0.01% | 5017 |
|